Synaptics officer plans $670K stock sale

SYNAPTICS Inc (SYNA) received a notice from officer Lisa Bodensteiner of her intent to sell company common stock under Rule 144.

Rhea-AI Filing Summary

SYNAPTICS Inc (SYNA) received a notice from officer Lisa Bodensteiner of her intent to sell company common stock under Rule 144. The filing lists up to 6,056 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, with a stated market value of $669,672.48 as of August 18, 2026, on NASDAQ. The notice also ties these shares to recently acquired equity awards, including restricted stock units and performance stock units dated August 17, 2026, and discloses prior 10b5-1 plan sales over the preceding three months.

Key Figures

Shares to be sold: 6,056 shares Aggregate market value of planned sale: $669,672.48 Restricted Stock Units related: 3,028 units +5 more

8 metrics

Shares to be sold 6,056 shares Common stock listed for sale under Rule 144 with Morgan Stanley Smith Barney LLC

Aggregate market value of planned sale $669,672.48 Value of 6,056 shares as of August 18, 2026

Restricted Stock Units related 3,028 units Common stock from Restricted Stock Units dated August 17, 2026

Performance Stock Units related 3,028 units Common stock from Performance Stock Units dated August 17, 2026

10b5-1 sale on July 20, 2026 450 shares for $51,735.20 Common stock sold in a 10b5-1 transaction for Lisa Bodensteiner

10b5-1 sale on June 18, 2026 334 shares for $46,185.52 Common stock sold in a 10b5-1 transaction for Lisa Bodensteiner

10b5-1 sale on May 19, 2026 612 shares for $70,275.96 Common stock sold in a 10b5-1 transaction for Lisa Bodensteiner

Planned sale reference date August 18, 2026 Reference date for NASDAQ sale and market value in the notice

Key Terms

Rule 144, Restricted Stock Units, Performance Stock Units, 10b5-1, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 08/17/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Performance Stock Units financial

"Common | 08/17/2026 | Performance Stock Units | Issuer"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

10b5-1 regulatory

"10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for SYNAPTICS Inc (SYNA)?

The filing reports officer Lisa Bodensteiner’s intention to sell up to 6,056 shares of SYNAPTICS common stock under Rule 144. It is a required disclosure of a planned sale, not a confirmation that all listed shares have been sold.

How many SYNA shares is Lisa Bodensteiner planning to sell under Rule 144?

Lisa Bodensteiner reports an intent to sell 6,056 shares of SYNAPTICS common stock. The filing cites an aggregate market value of $669,672.48 as of August 18, 2026, with sales to occur on NASDAQ through Morgan Stanley Smith Barney LLC.

What prior SYNA stock sales did Lisa Bodensteiner report in the last three months?

She disclosed three prior 10b5-1 sales of SYNAPTICS common stock: 450 shares on July 20, 2026, for $51,735.20; 334 shares on June 18, 2026, for $46,185.52; and 612 shares on May 19, 2026, for $70,275.96.

Which intermediary is handling the planned SYNA share sale?

The planned sale of up to 6,056 SYNA shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York. Transactions are indicated to occur on NASDAQ as of the August 18, 2026 reference date.

What equity awards are associated with the SYNA shares being reported?

The notice references Restricted Stock Units and Performance Stock Units from SYNAPTICS as the source of common stock. It lists 3,028 units for each award type, with an acquisition date of August 17, 2026, indicating recently vested equity being eligible for sale.

Are Lisa Bodensteiner’s SYNA sales under a 10b5-1 trading plan?

The filing states that sales during the past three months were 10b5-1 Sales for Lisa Bodensteiner. These include transactions on May 19, June 18, and July 20, 2026, which were executed under a pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 04:29 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001213272
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SYNAPTICS INCORPORATED
SEC File Number	000-49602
Address of Issuer	1109 McKay Drive San Jose CALIFORNIA 95131
Phone	4089041100
Name of Person for Whose Account the Securities are To Be Sold	LISA BODENSTEINER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6056	669672.48	39106986	08/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/17/2026	Restricted Stock Units	Issuer			3028	08/17/2026	N/A
Common	08/17/2026	Performance Stock Units	Issuer			3028	08/17/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	07/20/2026	450	51735.20
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	06/18/2026	334	46185.52
10b5-1 Sales for LISA BODENSTEINER 1109 McKay Drive San Jose CA 95131	Common	05/19/2026	612	70275.96

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Lisa Bodensteiner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)